For individuals with migraine frequency of 4 to 14 episodes per month, prophylactic medications and analgesics are required.
Anesthetic medications have been identified as a potential cause of morbidity in this population due to their interaction with the drugs used to manage Parkinson disease.
Under the new ischemic stroke guidelines, the treatment window for thrombectomy has been expanded to up to 24 hours after symptom onset.
There is a growing emphasis on provider responsibility with the increasing focus of the overprescribing of opioids.
Interventions aimed at motor and cognitive impairments in Huntington disease may result in long-term functional improvement.
Depression is one of the most commonly reported complications resulting from stroke.
Throughout the life course, higher body mass index and obesity are linked to cognitive decline, brain atrophy, reduced white matter and integrity of the blood-brain barrier, and elevated risk for late-onset Alzheimer disease.
Although pharmacotherapy remains the standard strategy for migraine management, there are many patients for whom nonpharmacological approaches are indicated.
Diagnosis of TB meningitis is challenging, although new, next-generation rapid POC testing holds promise for greatly improved sensitivity.